Navigation Links
WCCT Global (WCCT) & Verified Clinical Trials (VCT) Announce Medication Adherence Documentation Capabilities Have Been Added to the VCT Clinical Trials Database Registry
Date:1/2/2013

Cypress, CA, Costa Mesa, CA, Langhorne, PA, Garden City, NY (PRWEB) January 02, 2013

WCCT Global, a Full Service Contract Research Organization (CRO) supporting Phase I - IV biopharmaceutical and device development has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the US to help them enhance the capabilities of the VCT Clinical Trials Database Registry system. This new enhancement designed in collaboration with WCCT enables the Investigator to document study-participant adherence to medication schedules. Mel Affrime, Sr. VP R&D, WCCT said, “Patient adherence to clinical research protocol procedures, is critical along with returning to the investigational site for study procedures and safety assessments. This added enhancement now offered by VCT adds another level of security in the validity of the data that we capture for our clients”.

Mitchell Efros, MD, FACS, CEO and President of Verified Clinical Trials, stated "The recently released study medication adherence reminder system will improve dosing compliance in clinical trials. The module has the ability to remind the research volunteer to take the medication directly through the VCT registry. There is also the option of having the research subject respond to the reminder signaling their compliance and execution of the required dosing. WCCT Global, one of the early subscribers to our database, has always been an industry leader in their efforts to ensure the safety of their study participants and the quality of their clinical data. It has been a pleasure working with the WCCT team to make this enhancement available to our entire network of subscribers.”

About WCCT Global

WCCT Global is a multi-site, Full Service global Contract Research Organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive to for tomorrow’s therapies to be available today,” truly exemplifies the focus and reason for their cutting edge work. As a drug development partner, WCCT Global partners with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support with an emphasis on overseeing and executing on trials in special disease populations, ethnobridging volunteers, and cardiac safety . In addition, they extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Ophthalmology, Oncology, Renal, Serial ECGs, and Vaccines. Visit WCCT Global on the web at http://www.wcctglobal.com.

Contact for WCCT Global

Talia Nikolao
Vice President, Business Development
PR(at)wcct(dot)com
714-668-1500

About Verified Clinical Trials:

Verified Clinical Trials was developed by experts in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials halts dual enrollment in clinical trials and defines itself as the world's leader in the field of clinical trial database registries. Verified Clinical Trials is the only clinical research database registry that is fully web based and designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally and globally. Verified Clinical Trials is a HIPAA- and 21 CFR part 11- compliant online subject registry to anonymously and securely validate subjects and prevent dual enrollment in multiple concurrent research studies. Verified Clinical Trials offers numerous value-added services to the clinical research site, CRO, and pharmaceutical sponsor, that prove invaluable with regards to financial and legal issues and liabilities.

To RSVP or for more information, visit http://www.verifiedclinicaltrials.com.

Verified Clinical Trials Contact Info
Kerri Weingard, ANP, Chief Operating Officer
Verified Clinical Trials +1 516 998-7499

Read the full story at http://www.prweb.com/releases/trialdosingreminder/VerifiedClinicalTrials/prweb10269825.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... BETHESDA, Md. , March 23, 2017 /PRNewswire/ ... company developing DCVax® personalized immune therapies for solid ... on the $7.5 million financing it announced last ... Company sold to several institutional investors securities totaling ... $.26 per share, and 10,000,000 shares of Class ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring ... of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. ... activities. , “Dr. Floyd’s career has spanned 30 years in the chemicals and ...
Breaking Biology Technology:
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
(Date:3/7/2017)... 7, 2017 Brandwatch , the leading social intelligence ... Prince,s Trust to uncover insights to support its reporting, help ... The UK,s leading youth charity will be using Brandwatch Analytics ... get a better understanding of the topics and issues that are ... ...
(Date:3/2/2017)... LONDON , March 2, 2017 Who ... infringement lawsuits? Download the full report: https://www.reportbuyer.com/product/4313699/ ... ON THE FINGERPRINT SENSOR FIELD? Fingerprint sensors using ... smartphones. The fingerprint sensor vendor Idex forecasts an increase ... in mobile devices and of the fingerprint sensor market ...
Breaking Biology News(10 mins):